In the pivotal CREST clinical trial, sasanlimab in combination with Bacillus Calmette-Guérin met the primary endpoint of ...

One’s about behaviour, the other about emotions. Here’s how to respond to tantrums and meltdowns without losing your cool.

Results of part 1 of the ESSENCE phase 3 trial, published in The New England Journal of Medicine, demonstrated that a greater proportion ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

People with high blood pressure that is uncontrolled or poorly treated with most medications may benefit from a new drug that ...

A randomized controlled trial from North Carolina State University found that food processing minimally affects the ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced ...

Results from a clinical trial suggest that semaglutide, the substance in Ozempic and Wegovy, can halt and even reverse a ...

Sublingual delivery of epinephrine achieved pharmacokinetic and pharmacodynamic results that were comparable with manual ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...